BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

TG Therapeutics, Inc. 

787 Seventh Avenue
48th Floor
New York  New York  10019  U.S.A.
Phone: 212-554-4484 Fax: 212-554-4531


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Pharmaceutical






 Company News
TG Therapeutics, Inc. (MHA) Announces Special Protocol Assessment (SPA) Agreement With The FDA For Its First Phase 3 Clinical Trial Of TG-1101 (Ublituximab) In Combination With Imbruvica(R) (Ibrutinib) For Patients With Previously Treated Chronic Lymphocytic Leukemia 9/15/2014 7:52:45 AM
TG Therapeutics, Inc. (MHA) To Present At The 16th Annual Rodman & Renshaw Global Investment Conference 9/8/2014 7:58:58 AM
TG Therapeutics, Inc. (MHA) Announces Novel "Chemo-Free" Triple Therapy Combination Clinical Study For Patients With Chronic Lymphocytic Leukemia And Other B-Cell Malignancies 8/15/2014 7:53:00 AM
TG Therapeutics, Inc. (MHA) Announces Second Quarter 2014 Financial Results And Business Update 7/22/2014 2:41:50 PM
TG Therapeutics, Inc. (MHA) Completes Global Licensing Agreement With Ligand Pharmaceuticals Inc. (LGND) For The Development Of Inhibitors Of IRAK4 6/24/2014 8:58:40 AM
TG Therapeutics, Inc. (MHA) To Present At The 2014 JMP Securities Healthcare Conference 6/23/2014 7:32:49 AM
TG Therapeutics, Inc. (MHA) To Present At The 2014 Wells Fargo Healthcare Conference 6/17/2014 9:17:35 AM
TG Therapeutics, Inc. (MHA)' TG-1101 (Ublituximab) In Combination With Ibrutinib Demonstrates Compelling Clinical Activity And Safety Profile In Patients With Previously Treated Chronic Lymphocytic Leukemia (CLL) And Mantle Cell Lymphoma (MCL) 6/13/2014 8:32:12 AM
TG Therapeutics, Inc. (MHA) Announces Clinical Data Presentations For TG-1101 And TGR-1202 At The European Hematology Association Meeting In Milan, Italy 5/23/2014 10:14:13 AM
TG Therapeutics, Inc. (MHA) To Host Conference Call On First Quarter 2014 Financial Results And Business Update 5/9/2014 9:10:08 AM
12345678910...